Dr Byron Creese
Senior Research Fellow
RILD Building Level 4
My background is in psychology, which I studied to MSc level before undertaking my PhD in 2009 at King's College London in Prof Clive Ballard's group. After a brief period working in the Government Statistical Service at the Home Office, I returned to King’s in 2014 where I resumed work on the management of several large cohort studies – setting up key international collaborations in doing so - which would ultimately feed into the work I am leading at the University of Exeter focusing on the genetic basis of neuropsychiatric symptoms in Alzheimer's disease and other dementias.
I have also played a key role in the management of the South London and Maudsley Care Home Research Network (affiliated with the NIHR Biomedical Research Centre at King’s). I have also worked on several important studies evaluating the effectiveness of various interventions for neuropsychiatric symptoms in dementia, including management of the NIHR-funded DCM-EPIC study in London and a clinical trial evaluating memantine for the long-term treatment of agitation in dementia.
I have a particular interest in using genomic data to understand the aetiology of neuropsychiatric symptoms in dementia and the overlap with other diseases across the lifespan (e.g. schizophrenia, major depressive disorder). I have set up several key international collaborations to work towards this aim, most notably at the University of Stavanger, the Norwegian Centre for Research, Education and Service Development and the University of Oslo. I am currently leading a project using genomic data to identify genes and molecular pathways associated with key neuropsychiatric symptoms in dementia with a view to identifying new treatment targets.
Alongside my genetics work I also have expertise in the setting up and management of complex research projects, cohort studies and clinical trials, having managed numerous project funded by industry, NIHR and charities.
- A genetic epidemiology of psychosis and affective symptoms in dementia (two PhD projects: University of Exeter and King’s College London).
- A systematic programme to develop and evaluate the best candidate treatments for repositioning in Alzheimer’s Disease (SMART-AD)
- NIHR South London and the Maudsley Care Home Research Network
- Helse Stavanger Care Home Research Network, Norway
Publications by category
Publications by year
Conferences and invited presentations
- Webinar: GBA mutations and neuropsychiatric symptoms in Parkinson's disease, Clinical OMICS/Canon Biomedical, 11th October 2017.
- Clinical Trial Deigns for RCTs focussing on the Treatment of Agitation in people with Alzheimer’s disease, International Society for CNS Clinical Trials and Methodology autumn conference, Paris, France, 2nd September 2017.
- Genetics of Neuropsychiatric Symptoms in Dementia: an update, Centre for Age-Related Medicine (SESAM), Helse Stavanger annual conference, Stavanger, Norway 7th July 2017.
- Novel Approaches to Understanding the Mechanisms of the Neuropsychiatric Symptoms in Alzheimer’s and Advancing Therapy Development, National Institute on Aging/National Institute of Mental Health, Bethesda, USA 8-9th May 2017
- Genetics of Neuropsychiatric Symptoms in Dementia, Aging and Health: Norwegian Centre for Research, Education and Service Development annual conference, Demensdagen (‘Dementia Days’), Oslo, Norway, 7th December 2016.
- Genetics of psychosis in Lewy body dementias and Parkinson's disease, Lewy bodies & Parkinson’s dementia: unmet needs & emerging treatments, South London and the Maudsley NIHR Biomedical Research Centre, London, UK 12th April 2016.
- Genetics of Neuropsychiatric Symptoms in Dementia: opportunities for UK-Norway Collaboration. Centre for Age-Realted Medicine (SESAM), Helse Stavanger annual conference, Stavanger, Norway 9th February 2015.